Daniel G. Welch, Director at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 217 shares at $126.76 ($28K) on 2017-07-20, disclosed to the SEC on 2017-07-21.
Scheduled sale ($28k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2023-05-03 | $9.8M | — | Filing → |
| SGEN | SELL | 2023-04-05 | $12.5M | — | Filing → |
| SGEN | SELL | 2023-03-17 | $1.4M | — | Filing → |